当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:296.12亿  总市值:296.12亿
流通股本:28.53亿   总股本:28.53亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金20,292,035,951.8613,389,911,638.66,458,518,085.229,091,346,599.25
收到的税费返还459,602,997.84330,068,330.01154,396,803.23598,220,147.3
收到其他与经营活动有关的现金355,718,519.67302,955,156.78176,776,894.44343,744,773.05
经营活动现金流入的平衡项目0000
经营活动现金流入小计21,107,357,469.3714,022,935,125.396,789,691,782.8730,033,311,519.6
购买商品、接受劳务支付的现金14,374,153,645.819,916,642,628.25,764,735,765.2221,211,308,539.84
支付给职工以及为职工支付的现金1,531,863,315.081,120,919,599.52636,117,807.571,780,261,966.43
支付的各项税费606,174,050.88425,300,472.8219,132,820.941,131,976,118.37
支付其他与经营活动有关的现金509,454,533.85324,254,301.75200,107,751.08680,827,810.08
经营活动现金流出的平衡项目0000
经营活动现金流出小计17,021,645,545.6211,787,117,002.276,820,094,144.8124,804,374,434.72
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额4,085,711,923.752,235,818,123.12-30,402,361.945,228,937,084.88
二、投资活动产生的现金流量:
收回投资收到的现金12,840,00037,400,00065,493,055.5688,628,666.67
取得投资收益收到的现金24,609,93010,871,635.281,702,976.8531,215,210.8
处置固定资产、无形资产和其他长期资产收回的现金净额1,237,1961,065,812638,0004,600,429.92
投资活动现金流入的平衡项目0000
投资活动现金流入小计38,687,12649,337,447.2867,834,032.41124,444,307.39
购建固定资产、无形资产和其他长期资产支付的现金1,425,811,689.21,048,684,780.6387,432,533.211,333,258,499.81
投资支付的现金2,342,886,143.381,094,050,606.66171,617,566.67266,053,482.02
支付其他与投资活动有关的现金--596,64534,278,559.79
投资活动现金流出的平衡项目0000
投资活动现金流出小计3,768,697,832.582,142,735,387.26559,646,744.881,633,590,541.62
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-3,730,010,706.58-2,093,397,939.98-491,812,712.47-1,509,146,234.23
三、筹资活动产生的现金流量:
取得借款收到的现金4,914,588,328.043,556,386,998.941,835,264,148.924,065,122,989.15
收到其他与筹资活动有关的现金287,772,154.46235,856,949.53115,663,953.84441,674,397.67
筹资活动现金流入平衡项目0000
筹资活动现金流入小计5,202,360,482.53,792,243,948.471,950,928,102.764,506,797,386.82
偿还债务支付的现金5,106,015,680.693,573,136,295.581,616,845,233.464,984,013,700
分配股利、利润或偿付利息支付的现金1,268,690,731.641,171,823,531.224,059,899.521,325,273,487.51
支付其他与筹资活动有关的现金670,263,213.09503,808,378.73149,591,388.611,305,607,391.48
筹资活动现金流出平衡项目0000
筹资活动现金流出小计7,044,969,625.425,248,768,205.511,790,496,521.597,614,894,578.99
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,842,609,142.92-1,456,524,257.04160,431,581.17-3,108,097,192.17
四、汇率变动对现金及现金等价物的影响71,035,361.9668,078,736.5627,345,563.8540,121,088.53
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,415,872,563.79-1,246,025,337.34-334,437,929.39651,814,747.01
加:期初现金及现金等价物余额4,780,614,442.734,780,614,442.734,780,614,442.734,128,799,695.72
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,364,741,878.943,534,589,105.394,446,176,513.344,780,614,442.73
补充资料:
净利润-1,473,823,789.92-3,180,949,695.48
资产减值准备-1,987,907.91-5,415,349.06
固定资产和投资性房地产折旧-644,467,539.02-1,311,010,852.63
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-644,467,539.02-1,311,010,852.63
无形资产摊销-21,594,903.82-37,303,367.68
长期待摊费用摊销-14,792,568.72-26,321,001.29
处置固定资产、无形资产和其他长期资产的损失--1,598,224.17--2,679,296.59
固定资产报废损失-24,205,123.35-43,033,940.23
公允价值变动损失--1,959,926.94-38,116,002.85
财务费用--23,730,451.06-75,739,035.49
投资损失--14,671,408.04--7,627,189.35
递延所得税-23,261,630.32-48,141,185.11
其中:递延所得税资产减少-24,645,983.8-30,436,785.37
递延所得税负债增加--1,384,353.48-17,704,399.74
存货的减少-416,520,802.04-1,128,652,537.16
经营性应收项目的减少-253,649,805.16--23,422,883.89
经营性应付项目的增加--591,564,282.59--644,846,543.75
其他---3,715,965.28
现金的期末余额-3,534,589,105.39-4,780,614,442.73
减:现金的期初余额-4,780,614,442.73-4,128,799,695.72
公告日期2024-10-232024-07-302024-04-092024-03-19
审计意见(境内)标准无保留意见
TOP↑